These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 152680)

  • 1. Assay of an antitumor protein, neocarzinostatin, and its antibody by fluorescence polarization.
    Maeda H
    Clin Chem; 1978 Dec; 24(12):2139-44. PubMed ID: 152680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunoassay of neocarzinostatin, an antitumor protein.
    Samy TS; Raso V
    Cancer Res; 1976 Dec; 36(12):4378-81. PubMed ID: 63321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme immunoassay with high sensitivity and accuracy for specific antibody to neocarzinostatin.
    Kitagawa T; Tanimori H; Yoshida K
    J Immunol Methods; 1984 Aug; 72(1):297-303. PubMed ID: 6235292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of neocarzinostatin, a small cytotoxic protein used in cancer chemotherapy.
    Raso V
    Methods Enzymol; 1982; 84():483-90. PubMed ID: 6212749
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune suppression of anti-DNA antibody production using anti-idiotypic antibody-neocarzinostatin conjugates.
    Sasaki T; Koide Y; Yoshigaga K
    Methods Enzymol; 1989; 178():422-32. PubMed ID: 2532290
    [No Abstract]   [Full Text] [Related]  

  • 6. Assay of angiotensin I by fluorescence polarization method.
    Maeda H; Nakayama M; Iwaoka D; Sato T
    Adv Exp Med Biol; 1979; 120A():203-11. PubMed ID: 495309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental and clinical studies on the formation of antibodies to neocarzinostatin, a new protein antibiotic.
    Sakamoto S; Maeda H; Matsumoto T; Ogata J
    Cancer Treat Rep; 1978 Dec; 62(12):2063-70. PubMed ID: 156066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorophotometric enzyme immunoassay of neocarzinostatin using peroxidase as a label.
    Matsuoka K; Maeda M; Tsuji A
    Chem Pharm Bull (Tokyo); 1980 Jun; 28(6):1864-8. PubMed ID: 6447549
    [No Abstract]   [Full Text] [Related]  

  • 9. Degradation of neocarzinostatin by blood sera in vitro and its inhibition by diisopropyl fluorophosphate and n-ethylmaleimide.
    Maeda H; Takeshita J
    Gan; 1975 Oct; 66(5):523-7. PubMed ID: 130275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
    Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
    J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and fast purification of neocarzinostatin by FPLC-ion exchange chromatography.
    Denklau D; Köhnlein W; Lüders G; Stellmach J
    Z Naturforsch C Biosci; 1983; 38(11-12):939-42. PubMed ID: 6230805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of penicillin antibodies by fluorescence polarization and immunodiffusion.
    Dandliker WB; Halbert SP; Florin MC; Alonso R; Schapiro HC
    J Exp Med; 1965 Dec; 122(6):1029-48. PubMed ID: 4954960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of the primary interaction between 125I-labeled human hemoglobin and rabbit anti-human hemoglobin sera: a sensitive radioimmunoassay technique.
    Garver FA
    J Immunol Methods; 1975 Jun; 7(2-3):271-82. PubMed ID: 1170236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of proteolytic enzymes prevent the inactivation by blood of the protein antibiotic neocarzinostatin and its succinyl derivative.
    Maeda H; Takeshita J
    J Antibiot (Tokyo); 1976 Jan; 29(1):111-2. PubMed ID: 132416
    [No Abstract]   [Full Text] [Related]  

  • 15. An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.
    Sakamoto S; Maeda H; Ogata J
    Experientia; 1979 Sep; 35(9):1233-5. PubMed ID: 158538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate.
    Otsuji E; Tsuruta H; Toma A; Kobayashi S; Okamoto K; Yata Y; Yamagishi H
    Hepatogastroenterology; 2003; 50(50):380-4. PubMed ID: 12749227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay for aclacinomycin A.
    Matsuzawa Y; Kiyosaki T; Oki T; Takeuchi T; Umezawa H
    Gan; 1982 Apr; 73(2):229-33. PubMed ID: 6956531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of anti-neocarzinostatin (NCS) antibody production in leukemia patients treated with NCS.
    Toki H
    Acta Med Okayama; 1976 Apr; 30(2):135-42. PubMed ID: 135485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassays for methotrexate, citrovorum factor, neocarzinostatin, and actinomycin D.
    Raso V
    Cancer Treat Rep; 1977 Jul; 61(4):585-90. PubMed ID: 141980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol directly determined in serum by fluoroimmunoassay with magnetizable solid phase.
    Pourfarzaneh M; White GW; Landon J; Smith DS
    Clin Chem; 1980 May; 26(6):730-3. PubMed ID: 6768472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.